BRAF V600E+V600M

一个同时携带V600E和V600M突变的患者的案例研究表明，达巴芬尼具有疼痛的临床反应。
A case study of a single patient harboring both a V600E and a V600M mutation, dabrafenib was shown to acheive clinical response.